Literature DB >> 8159406

Harrington instrumentation without arthrodesis and consecutive distraction program for young children with severe spinal deformities. Experience and technical details.

C A Tello1.   

Abstract

The treatment of severe spinal deformities in childhood is a great challenge. The nonoperative treatment is not always successful, and correction with spinal fusion is not usually the most desirable goal because it may result in a straighter but shorter trunk. Spinal instrumentation without arthrodesis is an alternative to these difficult decisions that allows child growth with control of the deformity. At the same time that there is considerable improvement in the natural history of these deformities, this treatment presents great morbidity. The combination of Harrington instrumentation and consecutive distractions is a difficult program but it has been the best answer for these complicated patients up to now.

Entities:  

Mesh:

Year:  1994        PMID: 8159406

Source DB:  PubMed          Journal:  Orthop Clin North Am        ISSN: 0030-5898            Impact factor:   2.472


  4 in total

1.  Infantile scoliosis in Beals syndrome: the use of a non-fusion technique for surgical correction.

Authors:  Anthony Gwynne Martin; Pedro R Foguet; David S Marks; A G Thompson; A H Child
Journal:  Eur Spine J       Date:  2005-09-20       Impact factor: 3.134

2.  [Treatment of congenital scoliosis with the vertical expandable prosthetic titanium rib implant].

Authors:  A K Hell; F Hefti; R M Campbell
Journal:  Orthopade       Date:  2004-08       Impact factor: 1.087

3.  Dual Growing Rods for the Treatment of Early-Onset Scoliosis.

Authors:  Gregory M Mundis; Nima Kabirian; Behrooz A Akbarnia
Journal:  JBJS Essent Surg Tech       Date:  2013-03-27

4.  Traditional growing rod for early-onset scoliosis in high-altitude regions: a retrospective study.

Authors:  Haijun Jiang; Junrui Jonathan Hai; Peng Yin; Qingjun Su; Shiqi Zhu; Aixing Pan; Yunsheng Wang; Yong Hai
Journal:  J Orthop Surg Res       Date:  2021-08-10       Impact factor: 2.359

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.